Effect of Cord Blood Processing on Transplantation Outcomes after Single Myeloablative Umbilical Cord Blood Transplantation
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 01, 2015
- Source ID
- 10.1016/j.bbmt.2014.12.017
Entities
People
- Andromachi Scaradavou
- Arnon Nagler
- Brent R. Logan
- Daniel R. Ambruso
- David Oh
- Deepika Bhatla
- Elizabeth J. Shpall
- Gesine Koegler
- J. Douglas Rizzo
- Joanne Kurtzberg
- John R Wingard
- Joseph E. Kiss
- Karen K. Ballen
- Kathleen Sazama
- Lawrence D. Petz
- Lee Ann Weitekamp
- Leonard S. Sender
- Mary Eapen
- Mary J. Laughlin
- Michael W. Schuster
- Millicent Sutton
- Rachel L. Beddard
- Ralph R. Quinones
- Stephen R. Spellman
- Susan E. Armitage
- Thomas H. Price
- Voravit Ratanatharathorn
- Wensheng He
- William Y.k. Hwang
Organizations
- ARIAD Pharmaceuticals
- Actinium Pharmaceuticals (United States)
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- GSK
- Health Research
- HistoGenetics (United States)
- Incyte
- Medical College of Wisconsin
- Merck & Co.
- Miltenyi Biotec
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Roswell Park Comprehensive Cancer Center
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- St. Baldrick's Foundation
- StemCyte
- Swedish Orphan Biovitrum
- Tarix Orphan (United States)
- Terumo BCT (United States)
- University of Minnesota
- University of Utah